NCT03992677View on ClinicalTrials.gov

Feasibility of Improving Risk Stratification in Brugada Syndrome

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

December 1, 2020

Study Completion Date

August 1, 2022

Conditions
Brugada SyndromeCardiac ArrestAthletes HeartAtrial FibrillationVentricular Ectopic Beat
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

W12 0HS

Hammersmith Hospital, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT03992677 - Feasibility of Improving Risk Stratification in Brugada Syndrome | Biotech Hunter | Biotech Hunter